Yayınlar & Eserler

Yayın Ağı
Makaleler 42
Tümü (42)
SCI-E, SSCI, AHCI (35)
SCI-E, SSCI, AHCI, ESCI (41)
ESCI (6)
Scopus (42)
TRDizin (5)

1. Low Total IgE Predicts Non-Response to Omalizumab in Chronic Spontaneous Urticaria: A 10-Year Real-Life Study

Yegin Katran Z., BULUT İ., SALMAN A.
International Archives of Allergy and Immunology , cilt.187, sa.6, ss.605-615, 2026 (SCI-Expanded, Scopus)

2. Molecular IgE Reactivity Profiling With Micro-Arrayed Allergens Reveals Distinct Interregional Patterns of Sensitization and a Hypoallergenic Region in Türkiye

Kazancioglu A., Huang H., Aksakal S., BULUT İ., Buzan M., Chen K., et al.
Allergy: European Journal of Allergy and Clinical Immunology , cilt.81, sa.4, ss.1247-1264, 2026 (SCI-Expanded, Scopus)

3. Mind, Mucosa, and Skin: The Triad of Urticaria, Allergic Rhinitis, and Psychological Disorders

Katran Z. Y., BULUT İ., Salman A., Baz A., Küçükali G. M. K., Argin Ö.
Journal of Craniofacial Surgery , cilt.Publish Ahead of Print, 2026 (SCI-Expanded, Scopus)

4. Reclassification of NSAID hypersensitivity according to the WAO 2025 guidelines: insights from a cohort of 527 patients

BULUT İ., Katran Z. Y.
Allergologia et Immunopathologia , cilt.54, sa.1, ss.166-171, 2026 (SCI-Expanded, Scopus) Creative Commons License

5. Identifying future risk factors of uncontrolled asthma control: the TAAR study perspective

BOZKURT N., Abadoglu O., Onaran A. B. O., GÖKMEN D., KÖYCÜ BUHARİ G., AYDIN Ö., et al.
Journal of Asthma , cilt.63, sa.3, ss.339-349, 2026 (SCI-Expanded, Scopus)

6. Serum EDN as a novel biomarker for severe eosinophilic adult asthma

Özden Ş., Aynacı A., BULUT İ., Korkmaz Ş.
Allergologia et Immunopathologia , cilt.54, sa.4, ss.74-80, 2026 (SCI-Expanded, Scopus) Creative Commons License

7. Primary and steroid-induced antibody deficiency in severe asthma: a real-life analysis of a well-defined biologic-treated cohort

Yegin Katran Z., Argın Ö., BULUT İ.
Journal of Asthma , cilt.63, sa.8, ss.1034-1041, 2026 (SCI-Expanded, Scopus)

8. Adult IgE-mediated food allergy: clinical characteristics, predictors of severe reactions, and total IgE cut-off

Argın Ö., Katran Z. Y., BULUT İ.
Allergologia et Immunopathologia , cilt.54, sa.1, ss.145-153, 2026 (SCI-Expanded, Scopus) Creative Commons License

9. Exploring the link between nutritional status and total antioxidant status in patients with severe asthma: a cross-sectional study

TERZİ M., BULUT İ., Yakut T., Güneş F. E.
BMC Pulmonary Medicine , cilt.25, sa.1, 2025 (SCI-Expanded, Scopus)

10. What Does Radiologic Assessment Contribute to Asthma: A Subanalysis of the Turkish Adult Asthma Registry

KIZILIRMAK D., Uzun O., GÖKMEN D., AYDIN Ö., BAŞYİĞİT İ., Dursun A. B., et al.
Bratislava Medical Journal , cilt.126, sa.6, ss.1008-1022, 2025 (SCI-Expanded, Scopus)

11. Asthma patients with obesity have a unique phenotype: a subanalysis of the Turkish adult asthma registry

ÇELEBİ SÖZENER Z., OĞUZÜLGEN İ. K., ÖZALP ATEŞ F. S., Baccioglu A., ARGUN BARIŞ S., EDİGER D., et al.
Journal of Asthma , cilt.62, sa.7, ss.1183-1194, 2025 (SCI-Expanded, Scopus)

12. Trends in prescribing montelukast in patients with asthma in real-life: Results from the Turkish adult asthma registry

Beyaz Ş., Erdinç M., HAYME S., Aslan A. F., AYDIN Ö., GÖKMEN D., et al.
Allergologia et Immunopathologia , cilt.53, sa.1, ss.12-25, 2025 (SCI-Expanded, Scopus) Creative Commons License

13. Rapid drug desensitization with chemotherapy: when should omalizumab be considered?

BULUT İ., Katran Z. Y.
Allergologia et Immunopathologia , cilt.53, sa.4, ss.21-30, 2025 (SCI-Expanded, Scopus) Creative Commons License

14. Successful Desensitization with Ixekizumab in a Patient with a History of Multiple Biological Agent Allergy

Terzioglu Sahin F., Ozden S., BULUT İ.
Asthma Allergy Immunology , cilt.23, sa.1, ss.103-105, 2025 (ESCI, Scopus, TRDizin) Creative Commons License

15. Antituberculosis drug–induced hypersensitivity: clinical characteristics and risk factors

Katran Z. Y., BULUT İ., BABALIK A., Keren M., TEPETAM F. M.
Allergologia et Immunopathologia , cilt.53, sa.5, ss.69-77, 2025 (SCI-Expanded, Scopus) Creative Commons License

16. Fewer injections, less pain: Successful cyanocobalamin desensitization

Katran Z. Y., BULUT İ.
Allergologia et Immunopathologia , cilt.53, sa.3, ss.201-203, 2025 (SCI-Expanded, Scopus) Creative Commons License

17. A rare case of type IV hypersensitivity: Prilocaine allergy

Argın Ö., Demirkol M. A., Bozkurt Y., Yıldırım N., Katran Z. Y., BULUT İ.
Allergologia et Immunopathologia , cilt.53, sa.4, ss.134-137, 2025 (SCI-Expanded, Scopus) Creative Commons License

18. The cause of perioperative hypersensitivity in adults and consequences of subsequent anesthesia

Katran Z. Y., BULUT İ., Saydın F., Yavuz D., Cosar N. D., Katran M.
Allergologia et Immunopathologia , cilt.53, sa.2, ss.113-123, 2025 (SCI-Expanded, Scopus)

19. Old Questions, new answers: real-world long-term efficiency of hymenoptera venom immunotherapy: prevalance of venom-induced anaphylaxis, risk factors, and field sting reactions

Katran Z. Y., BULUT İ., Özşeker Z. F.
Allergologia et Immunopathologia , cilt.53, sa.2, ss.82-88, 2025 (SCI-Expanded, Scopus) Creative Commons License

20. A practical and applicable desensitization scheme for ciprofloxacin with a glass of water

Katran Z. Y., BULUT İ., Yegin F., Katran M.
Allergologia et Immunopathologia , cilt.53, sa.5, ss.135-137, 2025 (SCI-Expanded, Scopus) Creative Commons License

21. Socioeconomic status has direct impact on asthma control: Turkish adult asthma registry

ARSLAN B., TÜRK M., HAYME S., AYDIN Ö., GÖKMEN D., KÖYCÜ BUHARİ G., et al.
Clinical and Translational Allergy , cilt.15, sa.1, 2025 (SCI-Expanded, Scopus)

22. Factors influencing the prescription of add-on long-acting muscarinic antagonists in real-world asthma management: Insights from a national registry

GEMİCİOĞLU B., GÖKMEN D., Can A., SEVİNÇ C., OĞUZÜLGEN İ. K., SOYYİĞİT Ş., et al.
Respiratory Medicine , cilt.236, 2025 (SCI-Expanded, Scopus)

23. Distinct characteristics of asthma overlap phenotypes: Insights from the Turkish adult asthma registry

KEPİL ÖZDEMİR S., GEMİCİOĞLU B., Yildiz F., HAYME S., Alpagat G., BOZKURT N., et al.
Journal of Asthma , cilt.62, sa.9, ss.1512-1524, 2025 (SCI-Expanded, Scopus)

24. Economic burden of short-acting beta-2 agonist (SABA) overuse among asthma patients in Türkiye: a cost analysis with respect to the updated GINA treatment recommendations

YORGANCIOĞLU A. A., AKSU K., Cura C., Yaman Y., Dinç M., Malhan S., et al.
BMC Pulmonary Medicine , cilt.24, sa.1, 2024 (SCI-Expanded, Scopus)

25. Anaphylaxis in a country where Asia and Europe meet: Evaluation according to World Allergy Organization (WAO) and European Academy of Allergy and Clinical Immunology (EAACI) diagnostic criteria

BULUT İ., Yegin Katran Z., Yavuz D.
World Allergy Organization Journal , cilt.17, sa.9, 2024 (SCI-Expanded, Scopus)

26. Hypersensitivity Reaction and Rapid Drug Desensitization with Chemotherapeutics: A Tertiary Reference Center Experiences

BULUT İ., Yegin Katran Z.
International Archives of Allergy and Immunology , cilt.184, sa.9, ss.849-855, 2023 (SCI-Expanded, Scopus)

27. Drug hypersensitivity in drug-resistant tuberculosis

Katran Z. Y., BULUT İ., BABALIK A., Keren M., TEPETAM F. M., Mersin S. S., et al.
World Allergy Organization Journal , cilt.16, sa.5, 2023 (SCI-Expanded, Scopus)

28. Picturing asthma in Turkey: results from the Turkish adult asthma registry

Celik G. E., AYDIN Ö., GÖKMEN D., KÖYCÜ BUHARİ G., ÇELEBİ SÖZENER Z., GEMİCİOĞLU B., et al.
Journal of Asthma , cilt.60, sa.11, ss.1973-1986, 2023 (SCI-Expanded, Scopus)

29. Allergic Bronchopulmonary Aspergillosis Treated with Mepolizumab and Omalizumab: Switching Biological Agents

Katran Z. Y., BULUT İ.
Asthma Allergy Immunology , cilt.21, sa.2, ss.113-119, 2023 (ESCI, Scopus, TRDizin) Creative Commons License

30. Effectiveness of mepolizumab in patients with severe eosinophilic asthma: In a real life study Ağır eozinofilik astımlı hastalarda mepolizumab etkinliği: Bir gerçek yaşam çalışması

BULUT İ., Yegin Katran Z., Yavuz D., Akyildiz A. B., Yakut T., Örçen C., et al.
Tuberkuloz ve Toraks , cilt.71, sa.2, ss.148-155, 2023 (ESCI, Scopus, TRDizin) Creative Commons License

31. Short-acting β2-agonist prescription patterns in patients with asthma in Turkey: results from SABINA III

YORGANCIOĞLU A. A., AKSU K., Naycı S. A., EDİGER D., MUNGAN V. D., Gül U., et al.
BMC Pulmonary Medicine , cilt.22, sa.1, 2022 (SCI-Expanded, Scopus)

32. Management of type 1 immediate hypersensitivity reactions to antituberculosis drug: succesful desensitization

Katran Z. Y., BULUT İ., BABALIK A., Keren M.
Allergy, Asthma and Clinical Immunology , cilt.18, sa.1, 2022 (SCI-Expanded, Scopus)

33. Tuberculosis treatment-related lichenoid drug eruptions

Katran Z. Y., BULUT İ., BABALIK A.
International Journal of Mycobacteriology , cilt.11, sa.4, ss.469-471, 2022 (ESCI, Scopus)

34. Treatment and management of hypersensitivity reactions developed against anti-tuberculosis drug

Katran Z. Y., BULUT İ., BABALIK A., Keren M.
International Journal of Mycobacteriology , cilt.11, sa.3, ss.309-317, 2022 (ESCI, Scopus)

35. Psychiatric comorbidity and quality of life in patients with drug hypersensitivity

Beyaz S., Ersoy Y., Bicki E., Ak T., Taparli O. E., BULUT İ., et al.
Allergy and Asthma Proceedings , cilt.43, sa.3, ss.234-242, 2022 (SCI-Expanded, Scopus)

36. The significance of eosinophil and eosinophil lymphocyte ratio (Elr) in predicting response to omalizumab treatment in patients with severe allergic asthma Ağır alerjik astımı olan hastalarda omalizumab tedavi yanıtı öngörmede eozinofil ve eozinofil lenfosit oranının (Elr) önemi

Özgen H., TEPETAM F. M., BULUT İ., Örçen C.
Tuberkuloz ve Toraks , cilt.69, sa.1, ss.39-48, 2021 (ESCI, Scopus, TRDizin) Creative Commons License

37. Igfbp-4: A promising biomarker for lung cancer

SAVAŞ İ. N., Ozturk A., KAVAS M., BULUT İ., Alparslan S., Eroglu S. A., et al.
Journal of Medical Biochemistry , cilt.40, sa.3, ss.237-244, 2021 (SCI-Expanded, Scopus) Creative Commons License

38. Pregnancy-associated plasma protein-A (PAPP-A) levels in patients with severe allergic asthma are reduced by omalizumab

BULUT İ., Ozseker Z. F., COSKUN A., Serteser M., Unsal I.
Journal of Asthma , cilt.55, sa.10, ss.1116-1121, 2018 (SCI-Expanded, Scopus)

39. Visfatin and ghrelin: Can they be forthcoming biomarkers or new drug targets for asthma?

Toru Ü., Ayada C., Genç O., Şahin S., Arık Ö., Acat M., et al.
International Journal of Clinical and Experimental Medicine , cilt.8, sa.4, ss.6257-6261, 2015 (SCI-Expanded, Scopus)

40. Does aspirin use prevent acute coronary syndrome in patients with pneumonia: Multicenter prospective randomized trial

Oz F., Gul S., KAYA M., Yazici M., BULUT İ., Elitok A., et al.
Coronary Artery Disease , cilt.24, sa.3, ss.231-237, 2013 (SCI-Expanded, Scopus)

41. The effect of short and long term inhaler corticosteroid use on oral and periodontal health in asthmatic patients Astımlı hastalarda kısa ve uzun dönem inhaler kortikosteroid kullanımının oral ve periodontal saǧlık üzerine etkileri

ÖZCAN E., BULUT İ., Berk S., ÇANAKÇI C. F.
Duzce Medical Journal , cilt.13, sa.2, ss.16-22, 2011 (Scopus, TRDizin)

42. Relationship between pregnancy-associated plasma protein-A and lung cancer

BULUT İ., COSKUN A., Ciftci A., ÇETİNKAYA E., ALTIAY G., Caglar T., et al.
American Journal of the Medical Sciences , cilt.337, sa.4, ss.241-244, 2009 (SCI-Expanded, Scopus)
Metrikler

Yayın

42

Yayın (WoS)

41

Yayın (Scopus)

42

H-İndeks (WoS)

9

Atıf (Scopus)

275

H-İndeks (Scopus)

9

Atıf (TrDizin)

3

H-İndeks (TrDizin)

1

Atıf (Diğer Toplam)

3

Proje

1

Tez Danışmanlığı

2

Açık Erişim

16